164 related articles for article (PubMed ID: 9814049)
21. Device-associated nosocomial infection rates in intensive care units of seven Indian cities. Findings of the International Nosocomial Infection Control Consortium (INICC).
Mehta A; Rosenthal VD; Mehta Y; Chakravarthy M; Todi SK; Sen N; Sahu S; Gopinath R; Rodrigues C; Kapoor P; Jawali V; Chakraborty P; Raj JP; Bindhani D; Ravindra N; Hegde A; Pawar M; Venkatachalam N; Chatterjee S; Trehan N; Singhal T; Damani N
J Hosp Infect; 2007 Oct; 67(2):168-74. PubMed ID: 17905477
[TBL] [Abstract][Full Text] [Related]
22. Multidrug-resistant bacteria in hospitalized children: a 5-year multicenter study.
Raymond J; Nordmann P; Doit C; Vu Thien H; Guibert M; Ferroni A; Aujard Y
Pediatrics; 2007 Apr; 119(4):e798-803. PubMed ID: 17403822
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial resistance in clinical isolates of Staphylococcus aureus from hospital and community sources in southern Jamaica.
Brown PD; Ngeno C
Int J Infect Dis; 2007 May; 11(3):220-5. PubMed ID: 16815064
[TBL] [Abstract][Full Text] [Related]
24. [Impact of methicillin resistance in S. aureus].
Talon D
Pathol Biol (Paris); 1999 Oct; 47(8):819-26. PubMed ID: 10573702
[TBL] [Abstract][Full Text] [Related]
25. Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus: evidence of resistance to vancomycin.
Burnie J; Matthews R; Jiman-Fatami A; Gottardello P; Hodgetts S; D'arcy S
Clin Infect Dis; 2000 Sep; 31(3):684-9. PubMed ID: 11017816
[TBL] [Abstract][Full Text] [Related]
26. [Multiresistant bacteria in pediatrics].
Bonacorsi S; Bingen E
Pathol Biol (Paris); 1998 Apr; 46(4):261-7. PubMed ID: 9769906
[TBL] [Abstract][Full Text] [Related]
27. Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control.
Gould IM
Int J Antimicrob Agents; 2006 Nov; 28(5):379-84. PubMed ID: 17045462
[TBL] [Abstract][Full Text] [Related]
28. [Surveillance of multiresistant bacteria: justification, role of the laboratory, indicators, and recent French data].
Marty L; Jarlier V
Pathol Biol (Paris); 1998 Apr; 46(4):217-26. PubMed ID: 9769901
[TBL] [Abstract][Full Text] [Related]
29. An outbreak of Staphylococcus aureus strains with reduced susceptibility to glycopeptides in a French general hospital.
Pina P; Marliere C; Vandenesch F; Bedos JP; Etienne J; Allouch PY
Clin Infect Dis; 2000 Nov; 31(5):1306-8. PubMed ID: 11073773
[TBL] [Abstract][Full Text] [Related]
30. Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO).
Kluytmans-Vandenbergh MF; Kluytmans JA; Voss A
Infection; 2005 Oct; 33(5-6):309-13. PubMed ID: 16258859
[TBL] [Abstract][Full Text] [Related]
31. [Mechanisms underlying resistance of the bacteria responsible for nosocomial infections].
Mainardi JL; Gutmann L
Pathol Biol (Paris); 1998 Apr; 46(4):253-60. PubMed ID: 9769905
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial resistance of community and hospital acquired Staphylococcus aureus isolates to oxacillin and glycopeptides.
Anwar MS; Bokhari SR
J Coll Physicians Surg Pak; 2003 Jan; 13(1):33-6. PubMed ID: 12685973
[TBL] [Abstract][Full Text] [Related]
33. Trends in antimicrobial-drug resistance in Japan.
Arakawa Y; Ike Y; Nagasawa M; Shibata N; Doi Y; Shibayama K; Yagi T; Kurata T
Emerg Infect Dis; 2000; 6(6):572-5. PubMed ID: 11076714
[TBL] [Abstract][Full Text] [Related]
34. Methicillin resistance among Trinidadian isolates of community and hospital strains of Staphylococcus aureus and their patterns of resistance to non-beta-lactam antibiotics.
Orrett FA
Jpn J Infect Dis; 1999 Dec; 52(6):238-41. PubMed ID: 10738361
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial resistance in the hospital setting: impact, trends, and infection control measures.
Stein GE
Pharmacotherapy; 2005 Oct; 25(10 Pt 2):44S-54S. PubMed ID: 16178675
[TBL] [Abstract][Full Text] [Related]
36. [The role of hospital hygiene in the reduction of antibiotic resistance].
Pittet D
Bull Acad Natl Med; 2004; 188(8):1269-80; discussion 1280-1. PubMed ID: 15918657
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
Gilbert DN; Kohlhepp SJ; Slama KA; Grunkemeier G; Lewis G; Dworkin RJ; Slaughter SE; Leggett JE
Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375
[TBL] [Abstract][Full Text] [Related]
38. Prevention and control of methicillin-resistant Staphylococcus aureus.
Humphreys H; Grundmann H; Skov R; Lucet JC; Cauda R
Clin Microbiol Infect; 2009 Feb; 15(2):120-4. PubMed ID: 19291143
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic susceptibility and genotypic characterization of methicillin-resistant Staphylococcus aureus strains in eastern France.
Bertrand X; Thouverez M; Talon D
J Hosp Infect; 2000 Dec; 46(4):280-7. PubMed ID: 11170759
[TBL] [Abstract][Full Text] [Related]
40. [The drug resistance of pathogenic bacteria of nosocomial infections in surgical intensive care unit].
Chen J; Li LF; Guan XD; Chen DM; Chen MY; Ouyang B; Huang SW; Wu JF
Zhonghua Wai Ke Za Zhi; 2006 Sep; 44(17):1189-92. PubMed ID: 17147864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
